BPTF Drives Gastric Cancer Resistance to EGFR Inhibitor by Epigenetically Regulating the C‐MYC/PLCG1/Perk Axis
Fangyuan Li(Shanghai Jiao Tong University), Bingya Liu(Shanghai Jiao Tong University), Zhiyuan Fan(Shanghai First Maternity and Infant Hospital), Beiqin Yu(Ruijin Hospital), Tao Pan(Huazhong Agricultural University), Mengdi Chen(Dalian Medical University), Zhenggang Zhu(Wuhan Center for Disease Control and Prevention), Yingyan Yu(Fujian Medical University), Jianfang Li(Shanghai Jiao Tong University), Qingqing Sang(Shanghai Jiao Tong University), Liping Su(Guangdong Provincial People's Hospital), Yuanyuan Li(Anhui University), Xiongyan Wu(Ruijin Hospital), Junxian Yu(Fujian Medical University), Junyi Hou(Fudan University), Mingde Zang(Fudan University Shanghai Cancer Center), Haoran Feng(Shanghai Jiao Tong University), Chao Yan(Shanghai Jiao Tong University)
Cited by 17
Related Papers
IL-6 secreted by cancer-associated fibroblasts promotes epithelial-mesenchymal transition and metastasis of gastric cancer via JAK2/STAT3 signaling pathway
|Oncotarget|2017|400
miR-126 functions as a tumour suppressor in human gastric cancer
|Cancer Letters|2010|298
CD36 mediates palmitate acid-induced metastasis of gastric cancer via AKT/GSK-3β/β-catenin pathway
|Journal of Experimental & Clinical Cancer Research|2019|231
Tumor heterogeneity of gastric cancer: From the perspective of tumor-initiating cell
|World Journal of Gastroenterology|2018|212